A citation-based method for searching scientific literature

Megan J Bywater, Gretchen Poortinga, Elaine Sanij, Nadine Hein, Abigail Peck, Carleen Cullinane, Meaghan Wall, Leonie Cluse, Denis Drygin, Kenna Anderes, Nanni Huser, Chris Proffitt, Joshua Bliesath, Mustapha Haddach, Michael K Schwaebe, David M Ryckman, William G Rice, Clemens Schmitt, Scott W Lowe, Ricky W Johnstone, Richard B Pearson, Grant A McArthur, Ross D Hannan. Cancer Cell 2012
Times Cited: 384



Richard J Rebello, Eric Kusnadi, Donald P Cameron, Helen B Pearson, Analia Lesmana, Jennifer R Devlin, Denis Drygin, Ashlee K Clark, Laura Porter, John Pedersen, Shahneen Sandhu, Gail P Risbridger, Richard B Pearson, Ross D Hannan, Luc Furic. Clin Cancer Res 2016
Times Cited: 47




List of shared articles



Times cited

The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma.
Chang-Won Kang, Katherine M Hannan, Anneke C Blackburn, Amos H P Loh, Kuick Chik Hong, Goh Jian Yuan, Nadine Hein, Denis Drygin, Ross D Hannan, Lucy A Coupland. Invest New Drugs 2022
0

CX-5461 induces radiosensitization through modification of the DNA damage response and not inhibition of RNA polymerase I.
Stacey L Lehman, Kayla R Schwartz, Shrankhla Maheshwari, Kevin Camphausen, Philip J Tofilon. Sci Rep 2022
0

Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer.
Slađana Bursać, Ylenia Prodan, Nick Pullen, Jiri Bartek, Siniša Volarević. Trends Cancer 2021
20

The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer.
Shunfei Yan, Jiachen Xuan, Natalie Brajanovski, Madeleine R C Tancock, Piyush B Madhamshettiwar, Kaylene J Simpson, Sarah Ellis, Jian Kang, Carleen Cullinane, Karen E Sheppard,[...]. Br J Cancer 2021
15

HERC2 inactivation abrogates nucleolar localization of RecQ helicases BLM and WRN.
Mingzhang Zhu, Wenwen Wu, Yukiko Togashi, Weixin Liang, Yasuo Miyoshi, Tomohiko Ohta. Sci Rep 2021
6

Targeting treatment options for castration-resistant prostate cancer.
Dannah R Miller, Matthew A Ingersoll, Benjamin A Teply, Ming-Fong Lin. Am J Clin Exp Urol 2021
6

CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition.
Mitchell G Lawrence, Laura H Porter, Nicholas Choo, David Pook, Jeremy P Grummet, Carmel J Pezaro, Shahneen Sandhu, Susanne Ramm, Jennii Luu, Andrew Bakshi,[...]. Mol Cancer Ther 2021
4

Harnessing the Nucleolar DNA Damage Response in Cancer Therapy.
Jiachen Xuan, Kezia Gitareja, Natalie Brajanovski, Elaine Sanij. Genes (Basel) 2021
4

Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy.
Jian Kang, Natalie Brajanovski, Keefe T Chan, Jiachen Xuan, Richard B Pearson, Elaine Sanij. Signal Transduct Target Ther 2021
22

Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age.
Rita Ferreira, John S Schneekloth, Konstantin I Panov, Katherine M Hannan, Ross D Hannan. Cells 2020
65